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Abstract
OBJECTIVE—We examined the diabetes-fracture relationship by race/ethnicity, including the 
link between pre-diabetes and fracture.
RESEARCH DESIGN AND METHODS—We used Medicare- and mortality-linked data for 
respondents age 65 years and older from the third National Health and Nutrition Examination 
Survey (NHANES III) and NHANES 1999–2004 for three race/ethnic groups: non-Hispanic 
whites (NHW), non-Hispanic blacks (NHB), and Mexican Americans (MA). Diabetes was defined 
as diagnosed diabetes (self-reported) and diabetes status: diagnosed and undiagnosed diabetes 
(positive diagnosis or hemoglobin A1c (A1C) ≥ 6.5%); pre-diabetes (no diagnosis and A1C 
between 5.7%–6.4%); and no diabetes (no diagnosis and A1C < 5.7%). Non-skull fractures 
(n=750) were defined using published algorithms. Hazards ratios (HRs) were calculated using Cox 
proportional hazards models.
RESULTS—The diabetes-fracture relationship differed significantly by race/ethnicity (pinteraction 
<0.05). Compared to those without diagnosed diabetes, the HRs for those with diagnosed diabetes 
were 2.37 (95% CI 1.49–3.75), 1.87 (95% CI 1.02–3.40), and 1.22 (95% CI 0.93–1.61) for MA, 
NHB, and NHW, respectively, after adjusting for significant confounders. HRs for diagnosed and 
undiagnosed diabetes were similar to those for diagnosed diabetes alone. Pre-diabetes was not 
significantly related to fracture risk, however. Compared to those without diabetes, adjusted HRs 
for those with pre-diabetes were 1.42 (95% CI 0.72–2.81), and 1.20 (95% CI 0.96–1.51) for MA 
and NHW, respectively. There were insufficient fracture cases to examine detailed diabetes status 
in NHB.
CONCLUSIONS—The diabetes-fracture relationship was stronger in MA and NHB. Pre-
diabetes was not significantly associated with higher fracture risk, however.
1The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for 
Disease Control and Prevention.
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1. Introduction
Diabetes has been linked to an increased risk of fracture [1–14], but many aspects of this 
relationship remain unclear. For example, few previous studies have examined the diabetes-
fracture relationship in race/ethnic groups other than Caucasians [4, 6, 7], despite the higher 
prevalence of diabetes in many nonwhite groups [15]. There are also conflicting data 
regarding the relationship between pre-diabetes and fracture risk, as it has been associated 
with a significantly lower risk in some [9, 11], but not all [5, 6, 12, 16] studies published to 
date.
We used linked Medicare and mortality data for respondents age 65 years and older from the 
third National Health and Nutrition Examination Survey (NHANES III) and NHANES 
1999–2004 to address these data gaps. We examined differences in the diabetes-fracture 
relationship by race/ethnicity for three groups: non-Hispanic whites (NHW), non-Hispanic 
blacks (NHB), and Mexican Americans (MA). We also assessed the relationship between 
pre-diabetes and fracture risk after using data on diagnosed diabetes and whole blood 
hemoglobin A1c (A1C) to classify respondents as having diabetes, pre-diabetes, or no 
diabetes. Finally, we examined the relationship by diagnosed diabetes without regard to 
A1C values.
2. Research Design and Methods
2.1 Sample
The baseline data for this study came from NHANES III (1988–1994) and NHANES 1999–
2004, which were conducted by the National Center for Health Statistics (NCHS), Centers 
for Disease Control and Prevention, to assess the health and nutritional status of a large 
representative sample of the non-institutionalized, civilian population of the U.S. All 
procedures in each NHANES were approved by the NCHS Ethics Review Board, and 
written informed consent was obtained from all subjects [17, 18]. In each NHANES, data 
were collected via household interviews and direct standardized physical examinations 
conducted in specially equipped mobile examination centers [17, 18].
NHANES III and NHANES 1999–2004 were designed to provide reliable estimates for 
three race/ethnic groups: NHW, NHB, and MA. Race and ethnicity were self-reported in 
both surveys.
Both surveys were linked with mortality files created by NCHS and with Medicare 
enrollment and claims records in order to have a longitudinal follow-up of the survey 
participants. Vital status of study participants through 2007 was determined from the 
restricted access versions of the NHANES III and NHANES 1999–2004 Linked Mortality 
Files [19].
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Medicare enrollment and utilization data were available for NHANES respondents who 
agreed to provide personal identification [19]. Medicare claims data were provided from 
respondents who participated in fee-for-service care only from 1991 through 2007 for 
NHANES III and for 1999–2007 for NHANES 1999–2004. A list of the Medicare files used 
in the present study is provided in Supplementary Appendix 1.
The analytic sample in this study was restricted to respondents ages 65 years and older at the 
time of their NHANES interview at baseline because Medicare provides comprehensive 
health care for roughly 98% of the US population in this age range. Table A in 
Supplementary Appendix 2 shows the number of persons excluded from the analytic sample 
and reason for exclusion for each survey. After excluding a total of 2274 individuals, 2978 
(57%) of the original 5252 eligible interviewed individuals from NHANES III were 
included in the final analytic sample. After excluding a total of 2295 individuals, 2054 
(47%) of the original 4349 eligible interviewed individuals from NHANES 1999–2004 were 
included in the final analytic sample. Approximately 18% of the eligible interviewed sample 
from both surveys was excluded because they did not receive physical examinations; this 
nonresponse was addressed by inclusion of nonresponse adjustments in the creation of 
sample weights for the examined sample. Roughly 13% of the eligible sample was excluded 
due to prior fracture at baseline. A relatively large number of respondents in NHANES 
1999–2004 also were excluded because they were either ineligible for Medicare linkage2 
(10% excluded) or were enrolled in an HMO at baseline (12% excluded). Descriptive 
characteristics and risk factors were compared between the analytic sample and excluded 
respondents to assess possible nonresponse bias. The excluded respondents were older, more 
likely to be women, had higher body mass index (BMI), and self-rated their health as fair or 
poor than respondents who were included. There were no differences in self-reported 
diabetes diagnosis between included and excluded respondents, however.
2.2 Fracture case identification
Respondents with fractures at skeletal sites other than the skull were identified using an 
approach based on previously published methods [20–22]. Skull fractures were not included 
since they are unlikely to be due to osteoporosis [23]. Cases were defined using relevant 
International Classification of Disease (ICD), Healthcare Common Procedure Coding 
System (HCPCS) or Current Procedural Terminology (CPT) codes for the years 1991–2007 
[24, 25]. Respondents with codes indicating care of previous fracture or other bone diseases, 
neoplasm or hip arthroplasty for arthritis were excluded from the analyses. Details regarding 
the definition of cases from Medicare records, including the specific codes, are provided in 
Supplementary Appendix 1 or have been published previously [26]. Cause of death 
information from the NHANES Linked Mortality Files was also used to identify hip fracture 
cases. Specifically, decedents with an ICD-9 code 820 or ICD-10 code S72.0–S72.2 listed 
anywhere on the death certificate were defined as hip fracture cases.
2See Table A in Supplement 2 for ineligibility criteria.
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2.3 Variables
2.3.1 Diabetes status—Diabetes status was based on self-reported physician’s diagnosis 
of diabetes and on A1C levels in the main analyses in the present study. A1C was measured 
at the University of Missouri-Columbia in both surveys using high-performance liquid 
chromatography performed on instruments certified by the National Glycohemoglobin 
Standardization Program [27, 28]. A1C results were standardized to the reference method 
used for the Diabetes Control and Complications Trial [29]. Fasting plasma glucose (FPG) 
was used to define diabetes for a sensitivity analysis in non-Hispanic whites only because it 
was only available for a subsample whose blood was drawn in the morning, and there were 
insufficient fracture cases in this subsample to permit analyses in the other race/ethnic 
groups. Plasma glucose was measured at the University of Missouri-Columbia in both 
surveys using the enzyme hexokinase [27, 28].
Two definitions of diabetes status were used when examining fracture risk. Diagnosed 
diabetes (yes v. no) was based on the self-reported questionnaire item only. Women who 
reported diagnosis of diabetes during pregnancy only were not considered to have diagnosed 
diabetes. The more detailed definition of diabetes status used in the main analyses combined 
self-reported diagnosis and A1C values as follows: a) diabetes (diagnosed and undiagnosed): 
self-reported diagnosis or A1C ≥ 6.5%; b) prediabetes: no self-reported diagnosis and A1C 
between 5.7%–6.4%; c) no diabetes: no self-reported diagnosis and A1C < 5.7%. The 
detailed definition used in the sensitivity analysis based on FPG used the following criteria: 
a) diabetes: self-reported diagnosis or FPG ≥ 126 mg/dL; b) prediabetes: no self-reported 
diagnosis and FPG between 100–125 mg/dL; c) no diabetes: no self-reported diagnosis and 
FPG < 100 mg/dL. The sensitivity analyses were limited to NHW whose blood was drawn 
in the morning after fasting between 8–24 hours.
Some additional diabetes-related variables were explored to assess their role in the observed 
race/ethnic differences in the diabetes-fracture relationship. Undiagnosed diabetes was 
defined as having A1C ≥ 6.5% but no self-reported diabetes. Lower glycemic level was 
defined for those with a diabetes diagnosis as having A1C < 7.0% [30, 31]. Other variables 
related to diabetes status were obtained by interview and included self-reported age at 
diagnosis, duration of diabetes, and diabetes treatment. Duration of diabetes was calculated 
by subtracting age at diagnosis from age at baseline. Diabetes treatment was based on 
questionnaire items regarding current diabetes medication use. Responses were categories as 
insulin only, oral medications only, insulin plus oral medication, and neither insulin or oral 
medication.
2.3.2 Confounding or exclusion variables—Only variables that were measured 
comparably in the two surveys were used. Variables that were measured during the physical 
examination included body weight and height, which were used to calculate body mass 
index (BMI, equal to body weight (kilograms) divided by height (meters squared). Variables 
obtained by interview at baseline included age, self-reported race-ethnicity, self-reported 
hip, wrist or spine fracture, self-reported lower extremity amputations, smoking status (ever 
vs never), self-reported physical activity level compared to others of the same age and sex 
(same, higher, lower), self-rated health status (excellent/very good/good versus fair/poor), 
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maternal history of hip fracture, hospital stays in the past year (none versus ≥ 1), chronic 
conditions (self-reported diagnosis of heart attack, congestive heart failure, stroke, 
emphysema, or cancer), doctor visits in the past year (none, 1–3, ≥4), time since last doctor 
visit (< 1 year versus ≥ 1 year or never), education (< 12 years, 12 years, > 12 years), 
alcohol use (consume ≥ 3 drinks versus < 3 drinks per drinking occasion), current 
glucocorticoid use, and poverty income ratio. Poverty income ratio is based on the number 
of family members and the annual family income and is calculated using poverty thresholds 
from the US Census Bureau.
2.4 Statistical Analysis
All analyses were performed using SAS 9.3 (SAS Institute, Cary NC) and SUDAAN 
software (Research Triangle Institute, Research Triangle Park, NC) for analysis of data from 
complex sample surveys. Descriptive characteristics and risk factors at baseline were 
compared between fracture cases and non-cases using linear and log linear regression or chi-
square analyses. Cox proportional hazards models were used to model time to event and to 
calculate estimates of the hazards ratio (HR) for fracture by diabetes status. For fracture 
cases, length of follow-up was calculated as the time from date of examination to date of 
diagnosis or procedure for the fractures identified by Medicare records or date of death for 
hip fractures identified by death certificates but not by Medicare records. For non-fracture 
cases, follow-up time was calculated as time from baseline exam to date of death for 
decedents, date of entry into managed care for those who enrolled in a Medicare managed 
care program after their baseline examination, or end of follow-up (December 31, 2007) for 
all other respondents.
To assess the validity of pooling results for NHANES III and NHANES 1999–2004, a 
survey-by-diabetes interaction term was included in Cox models applied to the pooled 
sample from the two surveys. This interaction was not significant for either diagnosed 
diabetes (p=0.69) or detailed diabetes status (p=0.26), which indicates that the relationship 
between diabetes and fracture risk did not differ in the two surveys.
Secondary analyses were performed to assess the effect of adjusting the sample weights for 
nonresponse due to incomplete linkage or non-matches with Medicare data. Specifically, 
PROC WTADJUST was used to calculate sample weights that were adjusted for 
nonresponse in the Medicare linkage and results were compared with those obtained when 
the publicly-released sample weights that had not been adjusted for this nonresponse were 
used. Results were similar for both sets of sample weights, so only those based on the 
publicly-released sample weights are presented.
3. Results
A total of 750 non-skull fracture cases were identified in the analytic sample used in the 
present study. The distribution of fracture cases by skeletal site is shown in Table B in 
Supplementary Appendix 2. The four most common fractures were hip fracture (n=298), 
radius (n=122), tibia and fibula (n=67), and humerus (n=57). Baseline characteristics of non-
skull fracture cases versus non-cases are compared in Table 1. Fracture cases were older, 
had lower BMI, more likely to be white, and female than non-cases. They were more likely 
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to report similar physical activity levels as others of the same age and sex, but less likely to 
smoke and to report at least one hospital stay in the past year. None of the other baseline 
variables differed significantly by fracture status at baseline. Mean follow-up time was 6.7 
years (range 0.01—19.1 years) and mean age at fracture was 80.3 years.
The prevalence of diagnosed diabetes was 15% (n=897). The vast majority of these 
individuals were likely to have type 2 diabetes: only 27, or approximately 3%, of individuals 
with diagnosed diabetes met criteria consistent with type 1 diabetes (e.g., (e.g., reported a 
diabetes diagnosis before age 40 years and who currently used insulin only). Study results 
did not differ when these 27 individuals were excluded from the analytic sample, so they 
were retained. Nonetheless, study results essentially pertain to Type 2 diabetes.
Differences in the relationship between diabetes and fracture risk by age, sex, and race/
ethnicity were tested by including interaction terms in a single Cox model. The age-by-
diabetes and sex-by- diabetes interaction terms were not significant, but race/ethnicity-by-
diabetes interaction term was significant (p<0.05), so all subsequent analyses were 
performed separately by race/ethnicity.
Hazard ratios for any non-skull fracture by diabetes status and race/ethnicity are shown in 
Table 2 before and after adjusting for the significant risk factors identified in Table 1. NHB 
or MA with diagnosed diabetes were significantly more likely to experience a non-skull 
fracture than NHB or MA without a diabetes diagnosis before and after adjusting for several 
other significant fracture risk factors. Risk was approximately 1.9 times higher in NHB and 
2.3–2.4 times higher in MA. Non-skull fracture risk in NHW did not differ significantly by 
diabetes diagnosis status, however.
Hip fracture risk in NHW also did not differ significantly by diabetes diagnosis status (HR 
adjusted for age, sex, and survey =1.35, 95% CI 0.82, 2.22; n=222 hip fractures). There 
were insufficient hip fracture cases to permit analysis in NHB or MA.
HRs for non-skull fractures by detailed diabetes status are also shown in Table 2 for NHW 
and MA; there were insufficient non-skull fracture cases in NHB to permit this analysis. MA 
with diagnosed diabetes or elevated A1C were 2.2–2.7 times more likely to fracture than 
those without diabetes before and after adjusting for significant confounders. Risk in MA 
with pre-diabetes did not differ from risk in MA without diabetes, however. Among NHW, 
risk did not differ by detailed diabetes status.
The sensitivity analyses to compare HRs for non-skull fracture by detailed diabetes status 
using A1C or FPG criteria in NHW from the morning fasting subsample (n= 1305; 223 
fractures) revealed similar results. Compared to NHW without diabetes, the HR for NHW 
with diabetes was 1.21 (95% CI 0.79–1.85) when based on AIC and 1.20 (95% CI 0.94–
1.88) when based on FPG. Results for NHW with pre-diabetes were 1.02 (95% CI 0.77–
1.34) and 1.10 (95% CI 0.82–1.33) based on A1C and FPG, respectively.
To explore possible reasons for race/ethnic differences in fracture risk by diabetes, the risk 
factors that had differed significantly by fracture status, as well as the proportion with 
incident non-skull fractures, were compared by diabetes status separately by race/ethnicity 
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(Table 3). Differences in these relationships between race/ethnic groups were tested by 
including race-by-risk factor interaction terms in log linear models (Table 3). None of the 
interaction terms for the risk factors were statistically significant, which indicates that the 
relationship between diabetes and these risk factors did not differ by race/ethnicity. 
However, there was a significant interaction between race and diabetes for incident non-
skull fracture. When compared to those without diabetes, fewer NHW with diabetes had 
incident non-skull fractures, while the converse was true for NHB and MA. This finding is 
consistent with the lower HRs for fracture risk by diabetes status observed in NHW than in 
NHB or MA.
Selected characteristics of those with diabetes were also compared by race/ethnicity (Table 
3). Characteristics in those with diabetes that differed significantly between race/ethnic 
groups included age at diabetes diagnosis (NHW > NHB and MA), duration of diabetes 
(NHB > NHW), and the proportion with undiagnosed diabetes (NHB > NHW and MA). 
Finally, type of diabetes treatment differed by race/ethnicity. Compared to NHW, NHB with 
diabetes were more likely to use insulin, whereas MA were more likely to use oral 
medication.
4. Discussion
The association between fracture risk and diabetes differed significantly by race/ethnicity. 
Among NHB and MA, risk was 1.9–2.4 times higher in those with diabetes than in those 
without diabetes even after adjusting for several confounders. In contrast, risk in NHW with 
diabetes was only 1.2 times higher than among those without diabetes, and was not 
statistically significant. Other studies in whites have reported a similar modest increase in 
all-fracture risk. The risk estimate was significant in several [2, 6, 7, 9, 10, 16], but not all 
[5, 8], of these studies.
Few studies have examined the diabetes-fracture risk relationship in a multi-race/ethnic 
cohort. Our results are consistent with those from the Women’s Health Initiative 
Observational Study [7], where the risk of any fracture was somewhat higher in NHB 
women with diabetes (HR=1.33) than in NHW women (HR=1.18). However, no interaction 
between diabetes and fracture risk by race (white versus black) was observed in the Health 
ABC cohort [6]. Differences in the age range of the participants or methods to define 
diabetes and fracture outcomes could potentially account for these different results. To our 
knowledge, only one previous study has examined fracture risk by diabetes in MA [4]. Hip 
fracture risk was significantly higher in MA with diabetes than in MA without diabetes, but 
data for non-Hispanics were not available for comparison.
The reasons for a stronger relationship between diabetes and fracture in NHB and MA than 
in NHW are not clear. One possible explanation for this phenomenon is the higher absolute 
fracture risk in whites compared to blacks or Hispanics [32], which could act to attenuate the 
magnitude of relative effect estimates of fracture risk when comparing persons with a risk 
factor to persons without it. In the present study, the proportion of incident non-skull 
fractures was significantly higher among NHW without diabetes than in NHW with 
diabetes, which is consistent with this possibility. There were also some differences in 
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selected characteristics in those with diabetes that were consistent with higher fracture risk 
in NHB. For example, the proportion with undiagnosed diabetes, defined as A1C ≥ 6.5% in 
those without diagnosed diabetes, was significantly higher in NHB than in NHW. NHB with 
diabetes also differed significantly from NHW with diabetes on two other characteristics 
linked with increased fracture risk: longer diabetes duration [13, 14], and use of insulin [2, 8, 
10, 16].
Other studies have found race/ethnic differences in the relationship between diabetes and 
non-skeletal risk factors or health outcomes. For example, NHB and some South Asian 
groups appear to be at risk of developing diabetes at a lower BMI than whites [33], and 
NHB may be at risk of developing retinopathy at a lower A1C level than whites [34]. NHB 
and MA with diabetes also appear to have higher risk of mortality, end-stage renal disease, 
diabetes-related amputations, and retinopathy than NHW [34, 35, 36–38]. The mechanisms 
underlying these race/ethnic differences are not clear, but could include physiological, 
socioeconomic, and health care access factors [36, 37]. In the present study, all study 
respondents were Medicare participants, which may have reduced the impact of race/ethnic 
differences in diabetes control due to health care access [31]. The lack of a significant race/
ethnic difference in the proportion of diabetic persons with lower glycemic levels in the 
present study is consistent with this possibility.
The relationship between pre-diabetes and fracture risk has not been examined by race/
ethnicity previously to our knowledge. In the present study, HRs for fracture in NHW or 
MA with pre-diabetes, although above 1.00, were not statistically significant. Previous 
studies of impaired glucose tolerance or impaired fasting glucose have found either a 
reduced fracture risk [5, 9, 11] or no significant increase in risk [6, 12, 16]. Differences in 
the approaches used to define pre-diabetes may partially explain these variation in results, 
since use of different indicators to define pre-diabetes may identify a somewhat different 
group of individuals with the condition [39].
Study limitations include the potential impact of time trends in diabetes prevalence, 
complications, and treatment during the study period [30, 40]. However, the survey-by-
diabetes interaction term was not significant, which indicates that the relationship between 
diabetes and fracture was similar in those assessed in 1988–1994 versus 1999–2004. 
Another limitation was the inability to use FPG to define detailed categories of diabetes in 
all race/ethnic groups. Results of the sensitivity analyses performed in NHW revealed a 
similar diabetes-fracture relationship for both indicators. However, it is unclear whether the 
relationship would be similar in NHB or MA, since the relationship between A1C and FPG 
appears to differ by race/ethnicity [39]. Finally, we were unable to assess whether results 
differed by type of diabetes, due to the very limited number (n=27) of individuals who met 
criteria consistent with type 1 diabetes (.e.g, reported a diabetes diagnosis before age 40 
years and who currently used insulin only). An analysis of more recent NHANES data using 
slightly different criteria also found a very low prevalence of Type 1 diabetes in persons 
ages 60 years and older [41].
Other limitations include the inability to include some important intermediate variables that 
were not measured comparably in the two surveys, such as falls and bone mineral density, as 
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well as the limited number of fracture cases in MA and NHB. Fracture cases were identified 
using administrative records and were not verified by x-ray. However, Ray et al [20] 
reported positive predictive value and estimated sensitivity of 94% and 91%, respectively, 
for the combination of the fracture types examined in the present study other than spine 
fracture, which suggests the identified cases most likely suffered a fracture. Furthermore, 
misclassification of cases as non-cases would likely tend to attenuate the relative risk 
estimates observed between fracture risk and diabetes.
Results from the present study also apply only to the segment of the population ages 65 
years and older that was not institutionalized at baseline and participated in Medicare fee-
for-service programs because medical records for respondents who received care from 
managed care programs or in Veterans Administration facilities were not available. 
Exclusions for missing data or loss to follow-up were also made. The respondents who were 
excluded from the analytic sample were more likely to have some characteristics that are 
associated with greater fracture risk (older, female, and poorer health) than respondents who 
were included. Nonresponse to the baseline interview and examination is partially addressed 
by inclusion of nonresponse adjustments to the baseline sample weights, and additional 
adjustment to the weights to account for nonresponse to the Medicare linkage were 
evaluated in the present study to further address nonresponse. Nonetheless, although based 
on a cohort that was derived from nationally representative samples of the civilian, non-
institutionalized population at baseline, results from the present study cannot be generalized 
to the entire adult population over age 65 years.
In summary, the relationship between diagnosed diabetes and fracture was stronger in NHB 
and MA than in NHW. However pre-diabetes was not linked with a significant increase in 
fracture risk in NHW or MA, the two groups for which this relationship could be examined. 
Given the higher prevalence of diabetes in nonwhite groups in the U.S. [15], more work is 
needed to better understand the basis of the race/ethnic difference in the diabetes-fracture 
relationship.
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